Studying partial remission of type 1 diabetes in children: New biomarkers and the immunoregulatory role of microRNA

Research scientist using digital tablet to browse internet and find biochemistry discovery. Female chemist working with device to create pharmaceutical cure, microbiology experiment.

A study led by researchers from IGTP’s Immunology of Diabetes group has identified new microRNA as biomarkers for the partial remission phase, also known as “honeymoon phase,” of type 1 diabetes, and has linked the miR-30d-5p microRNA to immunoregulatory processes that may take place during this phase.

Trust in public health agencies during COVID-19 driven by beliefs that agencies led with science-based recommendations

Previous article

Halle Bailey reveals new ‘The Little Mermaid’ doll made in her likeness

Next article

You may also like


Leave a reply

Your email address will not be published. Required fields are marked *

More in Innovations